Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis
ConclusionIn summary, AH and INCS will remain the main groups of active ingredients in the treatment of allergic rhinitis in the future. In combination preparations such as the new combination nasal spray olopatadine hydrochloride-mometasone furoate, they are highly effective and safe, thus opening up new perspectives, especially for patients with moderate and severe allergic rhinitis from the age of 12 years.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Clinical Trials | Databases & Libraries | Germany Health | Hay Fever | Mometasone | Nasonex | Study